Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06400745 · ClinicalTrials.gov registry record · NA
Clareon PanOptix Pro vs. Clareon PanOptix - Study A
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
NCT06400745 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 87 participants.
The verdict
NCT06400745, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
Interventions
- PROCEDURE Cataract surgery
- DEVICE CPO Pro IOL
- DEVICE CPO IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2024-06-18 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06400745
The ClinicalTrials.gov registry entry for NCT06400745 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cataract surgery is the first listed.
NCT06400745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06400745 about?
NCT06400745 is a clinical study titled "Clareon PanOptix Pro vs. Clareon PanOptix - Study A". The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.
What is the current status of trial NCT06400745?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2024-06-18. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06400745?
The interventions under investigation include: Cataract surgery (PROCEDURE), CPO Pro IOL (DEVICE), CPO IOL (DEVICE).
Who is sponsoring clinical trial NCT06400745?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.